English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

cellulose/inflammation

The link is saved to the clipboard
Page 1 from 20 results

Anti-inflammatory effect of microfibrillated cellulose

Only registered users can translate articles
Log In/Sign up
CLAIM OF PRIORITY This application claims priority under 35 USC 371 to International Application No. PCT/FI2012/050129, filed on Feb. 10, 2012, which claims priority to Finland Application Serial No. 20115135, filed Feb. 11, 2011, each of which is incorporated by reference in its entirety. FIELD OF

Preparation for prevention and healing of inflammation affections

Only registered users can translate articles
Log In/Sign up
This application is a 371 of PCT/CZ98/00046 filed Oct. 2, 1998. TECHNICAL FIELD The invention relates to a preparation for prevention and healing of inflammation affections having a radical scavenging capacity with a large biological spectrum coverage. The preparation is applicable to the prevention

Ophthalmological composition of matter and a method for treatment of ocular inflammation by said composition

Only registered users can translate articles
Log In/Sign up
DESCRIPTION: The present invention relates to a new ophthalmological composition, the active ingredient of which is eicosapentaenoic acid. Eicosapentaenoic acid, abbreviated hereafter as "EPA", means cis-5, 8, 11, 14, 17-eicosapentaenoic acid of the formula ##STR1## EPA is a known polyunsaturated

Constant order release, solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions

Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION The present invention relates to an improved pharmaceutical formulation for indomethacin and more particularly relates to a solid dosage, constant order release indomethacin formulation. The number of people who have arthritis is increasing. It is currently estimated that

Bioadhesive extruded film for intra-oral drug delivery and process

Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a controlled-releasing medicament-containing preparation for intra-oral use, and is more especially concerned with such a preparation (and the process of using it) in the form of a very thin extruded thermoplastic

Nutritional composition

Only registered users can translate articles
Log In/Sign up
TECHNICAL FIELD The present invention relates to a nutrient composition (nutritional composition) having lipid metabolism-improving action. The nutrient composition highly effectively contributes to decrease of neutral lipids (triglycerides). The nutrient composition is expected to offer

Stable aqueous suspension

Only registered users can translate articles
Log In/Sign up
The present invention relates to a novel aqueous pharmaceutical suspension for homogeneously suspending at least one non-steroidal anti-inflammatory drug, a method of their production and their use in the treatment of disease, especially inflammatory diseases in humans and animals. Numerous

Spheroids

Only registered users can translate articles
Log In/Sign up
The present invention relates to a controlled release pharmaceutical composition containing a water-insoluble drug for administration to humans and/or animals. In the present specification the term "spheroid" means a spherical granule having a diameter of between 0.5mm and 2.5mm, especially between

Powdery pharmaceutical composition suitable for application to mucosa of oral or nasal cavity

Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a powdery pharmaceutical composition suitable for application to the mucosa of the oral or nasal cavity. More specifically, it relates to a powdery pharmaceutical composition, suitable for application to the

Compositions and methods for preventing or reducing postoperative ileus and gastric stasis

Only registered users can translate articles
Log In/Sign up
FIELD The present invention is directed to the prevention or reduction of postoperative ileus and gastric stasis. BACKGROUND Ileus is a major complication following abdominal surgery, and especially an abdominal surgery that involves manipulating the intestines and other abdominal organs.

Oral care composition for enhancing delivery of active agents to mucosa/soft oral tissue and tooth surfaces in the oral cavity

Only registered users can translate articles
Log In/Sign up
This application is a 371 of International Application No. PCT/EP2012/075082, filed Dec. 11, 2012, which claims the priority of GB Application No. GB 1121300.3 filed Dec. 12, 2011, which is incorporated herein in its entirety. FIELD OF THE INVENTION The present invention relates to oral care

Methods and compositions for rapid treatment of otitis externa

Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION The present invention relates to non-invasive methods and compositions for treating otitis externa (outer ear infection or infestation and inflammation) without use of a cellulose viscocity-enhancing component, gel or adhesive-based formulation. BACKGROUND OF THE

Absorbable composite materials for use in the treatment of periodontal disease

Only registered users can translate articles
Log In/Sign up
The present invention relates to absorbable composite materials in the form of a strip or film that are specially adapted for the treatment of periodontal disease. "Periodontal disease" is the term commonly used to describe inflammatory disease of the periodontium (tooth-surrounding tissue). It is a

Skin treating composition

Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION The present invention relates to a skin treating composition containing vitamin E; a blend comprising acetylated monoglyceride and polyoxyethylene fatty acid ester; a blend comprising distilled monoglyceride, distilled propylene glycol monoester, and sodium or calcium stearoyl

Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis

Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION This invention relates to orally administered low dose, topically acting corticosteroid compositions, useful for the treatment of conditions associated with inflammation of the esophagus. BACKGROUND OF THE INVENTION Esophageal inflammation disorders such as eosinophilic
Join our facebook page

The most complete medicinal herbs database backed by science

  • Works in 55 languages
  • Herbal cures backed by science
  • Herbs recognition by image
  • Interactive GPS map - tag herbs on location (coming soon)
  • Read scientific publications related to your search
  • Search medicinal herbs by their effects
  • Organize your interests and stay up do date with the news research, clinical trials and patents

Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research

Google Play badgeApp Store badge